2025-12-19 - Analysis Report
Okay, here's a comprehensive analysis of UnitedHealth Group (UNH) based on the provided data, presented in a structured format.

**0. Report Language:** English

**1. Return Rate Comparison**

*   **Ticker:** UNH (UnitedHealth Group Inc)
*   **Company Overview:** UnitedHealth Group is a diversified healthcare company providing health benefits and healthcare services.

    *   **UNH Cumulative Return:** -18.22%
    *   **VOO (S&P 500) Cumulative Return:** 99.09%
    *   **Divergence:** -116.5 (Range: -130.7 to 36.3, Relative Divergence: 8.5)

**Analysis of Alpha, Beta, CAGR, and MDD:**

The provided table shows a time-series analysis of UNH's performance against these key metrics:

*   **CAGR (Compound Annual Growth Rate):** Fluctuates significantly, showing periods of high growth (58% in 2015-2017) and substantial decline (-61% in 2023-2025).
*   **MDD (Maximum Drawdown):** Consistently high, ranging from 66.4% to 81.2%, indicating significant potential for loss from peak to trough. This is a major red flag.
*   **Alpha:** Measures outperformance relative to the benchmark. Alpha is negative in recent periods indicating underperformance.
*   **Beta:** Measures volatility relative to the market. Beta values range from 0.1 to 1.5, increasing substantially during times when the company is not performing well.
*   **Cap (B):** Market capitalization shown in billions.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 328.14
*   **Previous Close:** 331.63
*   **Change:** -1.05
*   **5-day SMA:** 335.38
*   **20-day SMA:** 329.19
*   **60-day SMA:** 340.41

**Analysis:** The stock price is currently below both its 5-day and 60-day SMAs, but around its 20-day SMA. This suggests a short-term downtrend and that it may bounce from its recent level.

**3. Index Indicators**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 48.81 (Neutral - neither overbought nor oversold)
*   **PPO:** 0.2572
*   **Hybrid Signal:** "cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Dividend_2.21 (Cash Ratio: 0% on 2025-12-08)" - The hybrid signal suggests a buy recommendation, but with caution.
*   **Recent (20 days) relative divergence change:** 2.3 (+) "단기상승" (Short-term increase)
*   **Expected Return (%):** -216.9 - Signalling significant long-term underperformance compared to the S&P 500.

**4. Recent News & Significant Events:**

*   **Reassessing Valuation After a 34% Share Price Drop:** Indicates concerns about the company's valuation.
*   **The Floor Is Set For Recovery:** Suggests potential for a rebound, but acknowledges the recent decline.
*   **Key Headlines, Analyst Forecasts, and What to Watch:** Signifies heightened investor interest and the need for careful monitoring.
*   **Most Negatives Appear Priced In; 2026 Could Be A Transition Year:** Implies that the market has already factored in the bad news, and that next year may be better.
*   **Falls More Steeply Than Broader Market:** Highlights UNH's recent underperformance relative to the overall market.
*   **Billionaire David Tepper Sells These 5 Stocks to Buy This 1 Stock:** It is important to see which stock David Tepper is buying.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.96)
*   **Target Price (avg/high/low):** 392.24 / 440.00 / 280.00

**Analysis:** Analyst sentiment is generally positive, with a "Buy" consensus and an average target price significantly above the current price. However, there is a wide range in target prices, indicating uncertainty.  It is important to see trends in the analyst ratings (if the recent changes are upgrades or downgrades).

**5. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-10-28 | 2.59 | 113.16 B$    |
| 2025-08-11 | 3.76 | 111.62 B$    |
| 2025-05-07 | 6.9  | 109.58 B$    |
| 2024-11-04 | 6.56 | 100.82 B$    |
| 2025-10-28 | 6.56 | 100.82 B$    |

**Analysis:** Revenue shows a steady upward trend. EPS is volatile, with a substantial drop in the most recent quarter. This discrepancy between revenue and EPS warrants further investigation.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue      | Profit Margin |
|------------|--------------|---------------|
| 2025-09-30 | $113.16B     | 18.24%        |
| 2025-06-30 | $111.62B     | 17.93%        |
| 2025-03-31 | $109.58B     | 21.70%        |
| 2024-12-31 | $100.81B     | 21.14%        |
| 2024-09-30 | $100.82B     | 22.84%        |

**Capital and Profitability:**

| Quarter    | Equity       | ROE   |
|------------|--------------|-------|
| 2025-09-30 | $95.79B     | 2.45% |
| 2025-06-30 | $94.72B     | 3.60% |
| 2025-03-31 | $95.04B     | 6.62% |
| 2024-12-31 | $92.66B     | 5.98% |
| 2024-09-30 | $94.53B     | 6.41% |

**Analysis:** Revenue continues to grow, but profit margins and ROE have declined in recent quarters. This is consistent with the decline in EPS. The increasing Equity also seems disconnected with the profitability, which warrants further investigation.

**7. Comprehensive Analysis (Summary):**

*   **Poor Recent Performance:** UNH has significantly underperformed the S&P 500. Its recent price action and the negative expected return further underscore this.
*   **High Risk:** The consistently high maximum drawdown (MDD) indicates significant volatility and risk.
*   **Declining Profitability:** While revenue is increasing, profit margins and ROE are declining. This is concerning and requires a deep dive into the company's expenses and operational efficiency.
*   **Analyst Optimism vs. Reality:** Despite the recent struggles, analysts maintain a "Buy" rating. This discrepancy could be due to expectations of a turnaround, but should be viewed with caution.
*   **Negative News Sentiment:** Recent news headlines reflect concerns about valuation and underperformance.
*   **Inconsistent Market Indicators:** The Market Risk Indicator suggests medium investment, while the Expected Return is extremely negative. The Hybrid Signal suggests a buy with caution, adding to the confusing picture.

**Conclusion:**

Based on the provided data, **UNH appears to be a risky investment at this time.** While analysts are generally positive and some news outlets suggest a potential recovery, the poor recent performance, declining profitability, high MDD, and negative expected return raise significant concerns.

**Recommendation:**

*   **Exercise caution:** Do not invest in UNH without further due diligence.
*   **Investigate the declining profitability:** Determine the underlying causes of the declining profit margins and ROE.
*   **Consider alternative investments:** Explore other opportunities with better risk-reward profiles.
*   **Monitor closely:** If you are already invested in UNH, closely monitor the company's performance and news flow.
*   **Re-evaluate analyst opinions:** Understand the reasoning behind the analyst "Buy" ratings and assess whether their assumptions are still valid.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.